{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:31:30Z","timestamp":1791207090381,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale"},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"name":"French Ministry of Research (Agence Nationale pour la Recherche)"},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.neuropharm.2011.01.025","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:24:00Z","timestamp":1296120240000},"page":"495-502","source":"Crossref","is-referenced-by-count":66,"title":["Implication of 5-HT2B receptors in the serotonin syndrome"],"prefix":"10.1016","volume":"61","author":[{"given":"Silvina Laura","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Maroteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.01.025_bib1","doi-asserted-by":"crossref","unstructured":"Banas, S., Doly, S., Boutourlinsky, K., Diaz, S., Belmer, A., Callebert, J., Collet, C., Launay, J.M.and Maroteaux, L., 2011. Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects. Neuropsychopharmacology 36, 423\u2013433.","DOI":"10.1038\/npp.2010.173"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0705328","article-title":"Evidence that central 5-HT2A and 5-HT(2B\/C) receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat","volume":"139","author":"Boothman","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1046\/j.1471-4159.2003.02267.x","article-title":"In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice","volume":"88","author":"Bortolozzi","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0028-3908(99)00191-4","article-title":"Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat","volume":"39","author":"Bristow","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1124\/jpet.105.098269","article-title":"Evidence for a control of plasma serotonin levels by 5-Hydroxytryptamine2B receptors in mice","volume":"317","author":"Callebert","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib6","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT2C receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib7","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/sj.npp.1301287","article-title":"Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies","volume":"32","author":"Cremers","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","article-title":"Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine2C receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/026988119701100303","article-title":"Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice","volume":"11","author":"Da-Rocha","year":"1997","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-002-1335-4","article-title":"Antidepressant-like effects in various mice strains in the forced swimming test","volume":"166","author":"David","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib12","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerdere","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib13","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.5723-07.2008","article-title":"Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro","volume":"28","author":"Doly","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-008-1268-7","article-title":"Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice","volume":"201","author":"Fox","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","article-title":"Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice","volume":"53","author":"Fox","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib31","first-page":"39","article-title":"A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim","volume":"34","author":"Golde","year":"2005","journal-title":"(NY)"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2005.12.075","article-title":"Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats","volume":"532","author":"Izumi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.npp.1300664","article-title":"Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice","volume":"30","author":"Jones","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neuint.2007.08.015","article-title":"Perspectives on genetic animal models of serotonin toxicity","volume":"52","author":"Kalueff","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(85)90290-0","article-title":"Central serotonergic responses and behavioral adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone","volume":"119","author":"Kennett","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1460-9568.2006.04917.x","article-title":"Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice","volume":"24","author":"Landry","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib22","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1096\/fj.06-5724com","article-title":"Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells","volume":"20","author":"Launay","year":"2006","journal-title":"FASEB. J."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00213-004-2044-y","article-title":"Implication of 5-HT(2) receptor subtypes in the mechanism of action of antidepressants in the four plates test","volume":"179","author":"Nic Dhonnchadha","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.01.025_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2005.04.025","article-title":"Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action","volume":"516","author":"Tatarczynska","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-200412000-00001","article-title":"Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression","volume":"15","author":"Tatarczynska","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.neubiorev.2005.03.020","article-title":"Mutant mouse models of depression: candidate genes and current mouse lines","volume":"29","author":"Urani","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00008877-200207000-00008","article-title":"Role of 5-HT2 receptors in the tryptamine-induced 5-HT syndrome in rats","volume":"13","author":"Van Oekelen","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.025_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2009.05.008","article-title":"Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome","volume":"615","author":"Zhang","year":"2009","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:43:19Z","timestamp":1740894199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0028390811000360"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}